Table 1. Different treatments from day 0 to day 4 in 6 different groups.
Group | 0–2 days | 3–4 days |
---|---|---|
F | Null | FGF2 |
FB | Null | FGF2+BMP4 |
BFB | BMP4 | FGF2+BMP4 |
CF | CHIR99021 | FGF2 |
CFB | CHIR99021 | FGF2+BMP4 |
CBFB | CHIR99021+BMP4 | FGF2+BMP4 |
BMP4, bone morphogenetic protein 4; CHIR99021, combination of GSK3β inhibitor; FGF2, fibroblast growth factor 2.